Study Details To Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy
Protocol Number VIS649
Phase II
Therapeutic Area Nephrology
Subject Types With Medical Condition
Indication Immunoglobulin A (IgA) Nephropathy
Principal Investigator A/Prof Jimmy Teo Boon Wee
Investigator Product / Device VIS649
Sponsor Visterra, Inc.
Top